Key Insights

Highlights

Success Rate

66% trial completion

Published Results

15 trials with published results (27%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 74/100

Termination Rate

23.2%

13 terminated out of 56 trials

Success Rate

65.8%

-20.7% vs benchmark

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

60%

15 of 25 completed with results

Key Signals

15 with results66% success13 terminated

Data Visualizations

Phase Distribution

53Total
Not Applicable (26)
Early P 1 (3)
P 1 (5)
P 2 (17)
P 3 (1)
P 4 (1)

Trial Status

Completed25
Terminated13
Recruiting6
Active Not Recruiting6
Withdrawn3
Unknown2

Trial Success Rate

65.8%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (56)

Showing 20 of 20 trials
NCT04849871Not ApplicableActive Not Recruiting

Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma

NCT04852887Phase 3RecruitingPrimary

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

NCT05535192Not ApplicableRecruiting

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

NCT05318274Not ApplicableActive Not Recruiting

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

NCT05595577Not ApplicableRecruiting

Improving Exercise Capacity With a Tailored Physical Activity Intervention

NCT04589468Not ApplicableActive Not Recruiting

Researching the Effect of Exercise on Cancer

NCT07042581Phase 4Recruiting

A Study of Revaree Plus in People With Breast Cancer

NCT06811454Not ApplicableNot Yet Recruiting

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

NCT04578106Phase 2Terminated

Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy

NCT03345420Phase 2Completed

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

NCT03284346Not ApplicableTerminated

Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors

NCT07095114Not ApplicableRecruiting

A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

NCT04584255Phase 2Active Not RecruitingPrimary

Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

NCT04007770Phase 2Active Not RecruitingPrimary

Acupuncture Pilot Study for Cancer-related Cognitive Function

NCT03198286Not ApplicableCompletedPrimary

Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors

NCT02129686Not ApplicableCompleted

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

NCT02096588Phase 2Terminated

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

NCT03139435Not ApplicableCompleted

Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer

NCT02240836Not ApplicableActive Not Recruiting

Energy Balance and Breast Cancer Aspects-II

NCT00019643Terminated

Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Scroll to load more

Research Network

Activity Timeline